Advaita Corporation develops bioinformatics software tools for the research and pharmaceutical industries. Through its $2.2M NIH STTR Phase II award, Advaita developed a software platform called Pathway-Guide for the analysis of data from high-throughput microarray and next-generation sequencing experiments. Advaita is the only company in the bioinformatics technology sector that focuses on the pathway analysis rather than data curation. Our philosophy is that no matter how detailed your map is, you can only explore as well as you can navigate. We are providing the GPS engine of pathway analysis. Innovators in Pathway Analysis Advaita offers the most advanced tool for pathway-level analysis of high-throughput data such as microarray and next-generation sequencing (RNA-Seq) data. Pathway-Guide is the only tool available on the market that incorporates the topology of the pathway into the analysis. This advanced analysis methodology not only provides more accurate results but also reduces the number of false-positive results. Innovators in Target Identification Pathway-Guide is the only tool capable of identifying points of therapeutic intervention. The software accomplishes this by measuring the accumulated perturbation in a coherent cascade on the subject pathway. Pathway-Guide then highlights these sections of the pathway so researchers can easily identify specific points of interest.